May 7, 2025

Real Estate

Technology

FDA lifts clinical hold on Atara’s lead treatment

Atara Biotherapeutics Research Center in Thousand Oaks. (courtesy photo) Thousand Oaks-based Atara Biotherapeutics received a bit of good news on May 5, after the U.S. Food and Drug Administration announced that it has lifted its hold on Atara’s active Investigational New Drug application for the Ebvallo program. Ebvallo, which is already approved in Europe and is used for transplant-related blood cancer, was placed on a clinical hold by the FDA Read More >

Newsmakers

Sponsored Content
Marlen Torres

Gold Coast Health Plan

Jessica Mullinix

Brownstein Hyatt Farber Schreck

ADVERTISING

Reach our audience with your message

Pacific Coast Business Times provides marketers with access to an affluent, educated business community of decision-makers via multimedia formats. Whichever media format or combination of media you choose, the Business Times helps you reach your marketing and sales goals.

Connect with our audience

94%

Answered the Business Times had influenced their buying decisions.

92%

Read the Pacific Coast Business Times for business news.

78%

Have obtained a four-year college degree.